
    
      Subjects in the group that was previously primed with Tritanrix™-HepB/Hiberix™ will be the
      control group for the group that was previously primed with Tritanrix™-HepB/Hib-MenAC.

      Blood samples will be drawn from subjects as follows:

        -  prior to and one month after the full dose of the Mencevax™ ACWY vaccine.

        -  prior to and one month after 1/5th of a dose of Mencevax™ ACWY vaccine (only for the
           first 75 subjects in each of the two centers).
    
  